` ALPHS (Pharmasimple SA) vs DAX Index Comparison - Alpha Spread

ALPHS
vs
D
DAX Index

Over the past 12 months, ALPHS has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +12% growth.

Stocks Performance
ALPHS vs DAX Index

Loading
ALPHS
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALPHS vs DAX Index

Performance Gap Between ALPHS and GDAXI
HIDDEN
Show

Performance By Year
ALPHS vs DAX Index

Loading
ALPHS
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Pharmasimple SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Pharmasimple SA
Glance View

Market Cap
124.5k EUR
Industry
Retail

Pharmasimple SA offers online sales of para-pharmaceutical products. The company is headquartered in La Louviere, Hainaut. The company went IPO on 2016-11-17. The firm operates the Website, through which sells pharmaceutical and cosmetics products. Its products portfolio encompasses drugs, food supplements, hygiene, face, body, hair, baby, man, solar, dietetic products, face accessories, anti-aging cream, cleansing cotton, eye contour, eye make-up remover, foaming gel, scrub, cleansing oil, cleansing milk, cleansing wipes, micellar lotion, makeup, mask, foam, oily skin, mixed skin, dry skins, serum, lip sticks, anti-stain care, anti-redness treatment , matifying care, young skin care tonic, and waxing bath sponges and brushes, among others.

ALPHS Intrinsic Value
Not Available
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett